⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for hank

Every month we try and update this database with for hank cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung CancerNCT03574649
Non Small Cell ...
Nab-paclitaxel
Cisplatin
5Fluorouracil
Cyclophosphamid...
ETBX-011
ETBX-051
ETBX-061
GI-4000
GI-6301
Aldoxorubicin
Avelumab
ALT-803
haNK
Docetaxel
carboplatin
18 Years - ImmunityBio, Inc.
QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyNCT03169764
Head and Neck S...
Avelumab
Bevacizumab
Capecitabine
Cetuximab
Cisplatin
cyclophosphamid...
5-Fluorouracil ...
fulvestrant
leucovorin
nab-paclitaxel
nivolumab
Lovaza
Stereotactic Bo...
ALT-803
ETBX-011
ETBX-021
ETBX-051
ETBX-061
GI-4000
GI-6207
GI-6301
haNK
18 Years - ImmunityBio, Inc.
QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsNCT03169738
Non-small Cell ...
avelumab
Bevacizumab
Capecitabine
Cisplatin
cyclophosphamid...
5-Fluorouracil ...
fulvestrant
leucovorin
nab paclitaxel
nivolumab
Lovaza
Oxaliplatin
Stereotactic Bo...
ALT-803
ETBX-011
ETBX-021
ETBX-051
ETBX-061
GI-4000
GI-6207
GI-6301
haNK
18 Years - ImmunityBio, Inc.
QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based ChemotherapyNCT03175666
Triple Negative...
avelumab
bevacizumab
capecitabine
cisplatin
cyclophosphamid...
5-Fluorouracil
Leucovorin
nab-paclitaxel
Lovaza
Stereotactic Bo...
ALT-803
ETBX-011
ETBX-051
ETBX-061
GI-4000
GI-6207
GI-6301
haNK
18 Years - ImmunityBio, Inc.
QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsNCT03169738
Non-small Cell ...
avelumab
Bevacizumab
Capecitabine
Cisplatin
cyclophosphamid...
5-Fluorouracil ...
fulvestrant
leucovorin
nab paclitaxel
nivolumab
Lovaza
Oxaliplatin
Stereotactic Bo...
ALT-803
ETBX-011
ETBX-021
ETBX-051
ETBX-061
GI-4000
GI-6207
GI-6301
haNK
18 Years - ImmunityBio, Inc.
QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyNCT03197571
Urothelial Carc...
avelumab
bevacizumab
capecitabine
cisplatin
cyclophosphamid...
5Fluorouracil (...
fulvestrant
leucovorin
nab-paclitaxel
Lovaza
Stereotactic Bo...
ALT-803
ETBX-011
ETBX-021
ETBX-051
ETBX-061
GI-4000
GI-6207
GI-6301
haNK
18 Years - ImmunityBio, Inc.
QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRCNCT03169777
Colorectal Canc...
avelumab
bevacizumab
capecitabine
cetuximab
Cyclophosphamid...
5-Fluorouracil ...
fulvestrant
leucovorin
nab paclitaxel
nivolumab
Lovaza
oxaliplatin
Stereotactic Bo...
ALT-803
ETBX-011
ETBX-021
ETBX-051
ETBX-061
GI-4000
GI-6207
GI-6301
haNK
18 Years - ImmunityBio, Inc.
QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsNCT03169738
Non-small Cell ...
avelumab
Bevacizumab
Capecitabine
Cisplatin
cyclophosphamid...
5-Fluorouracil ...
fulvestrant
leucovorin
nab paclitaxel
nivolumab
Lovaza
Oxaliplatin
Stereotactic Bo...
ALT-803
ETBX-011
ETBX-021
ETBX-051
ETBX-061
GI-4000
GI-6207
GI-6301
haNK
18 Years - ImmunityBio, Inc.
QUILT 3.071: NANT Colorectal Cancer (CRC) VaccineNCT03563157
Colorectal Canc...
mCRC
Aldoxorubicin H...
ALT-803
ETBX-011
ETBX-021
ETBX-051
ETBX-061
GI-4000
GI-6207
GI-6301
haNK
Avelumab
Capecitabine
Cetuximab
Cyclophosphamid...
5-Fluorouracil
Leucovorin
Nab-paclitaxel
Oxaliplatin
Regorafenib
SBRT
18 Years - ImmunityBio, Inc.
QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 TherapyNCT03167177
Melanoma
Avelumab
Bevacizumab
Capecitabine
Cisplatin
Cyclophosphamid...
5-fluorouracil
Leucovorin
nab-paclitaxel
Nivolumab
omega-3-acid et...
Stereotactic Bo...
ALT-803
ETBX-011
ETBX-051
ETBX-061
GI-6207
GI-6301
haNK
18 Years - ImmunityBio, Inc.
QUILT-3.088: NANT Pancreatic Cancer VaccineNCT03563144
Metastatic Panc...
Gemcitabine
Nab-paclitaxel
Aldoxorubicin H...
ALT-803
ETBX-011
ETBX-021
ETBX-051
ETBX-061
GI-4000
GI-6207
GI-6301
haNK
Avelumab
Bevacizumab
Capecitabine
Cyclophosphamid...
5-Fluorouracil
Leucovorin
Oxaliplatin
18 Years - ImmunityBio, Inc.
QUILT-3.088: NANT Pancreatic Cancer VaccineNCT03563144
Metastatic Panc...
Gemcitabine
Nab-paclitaxel
Aldoxorubicin H...
ALT-803
ETBX-011
ETBX-021
ETBX-051
ETBX-061
GI-4000
GI-6207
GI-6301
haNK
Avelumab
Bevacizumab
Capecitabine
Cyclophosphamid...
5-Fluorouracil
Leucovorin
Oxaliplatin
18 Years - ImmunityBio, Inc.
QUILT-3.088: NANT Pancreatic Cancer VaccineNCT03563144
Metastatic Panc...
Gemcitabine
Nab-paclitaxel
Aldoxorubicin H...
ALT-803
ETBX-011
ETBX-021
ETBX-051
ETBX-061
GI-4000
GI-6207
GI-6301
haNK
Avelumab
Bevacizumab
Capecitabine
Cyclophosphamid...
5-Fluorouracil
Leucovorin
Oxaliplatin
18 Years - ImmunityBio, Inc.
QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) VaccineNCT03554109
Triple Negative...
Leucovorin
5-Fluorouracil
Aldoxorubicin H...
nab-Paclitaxel
ETBX-011
ETBX-051
ETBX-061
GI-4000
GI-6207
GI-6301
Avelumab
ALT-803
haNK
Cyclophosphamid...
Doxorubicin HCL
paclitaxel
18 Years - ImmunityBio, Inc.
QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung CancerNCT03574649
Non Small Cell ...
Nab-paclitaxel
Cisplatin
5Fluorouracil
Cyclophosphamid...
ETBX-011
ETBX-051
ETBX-061
GI-4000
GI-6301
Aldoxorubicin
Avelumab
ALT-803
haNK
Docetaxel
carboplatin
18 Years - ImmunityBio, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: